Gender Bias and Overtreatment in Primary Care

Any Condition Clinical Trial

Official title:

Epidemiological Study on Gender Bias and Overtreatment in Primary Care Setting

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05745688
• Other study ID #: OVERGEND Data
• Status: Completed
• Start date: April 1, 2023
• Est. completion date: May 10, 2023

Study information

• Verified date: May 2023
• Source: Universidad Miguel Hernandez de Elche
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to analyze if there are differences between men and women in the frequency of ignoring "Do not do" recommendations in primary care setting.

Description:

First, using the Delphi technique, a consensus will be reached on those "Do Not Do" recommendations that should be included in the retrospective analysis study. The selection criteria for these recommendations will be if they are about pharmacological treatments, considered to persist in clinical practice in primary care, their relationship with factors associated with sex and gender, and if ignoring the "Do not do" recommendation could cause a serious adverse event.

Second, a retrospective cohort study will be carried out including patients who attended primary care consultation in Alicante from 1st January 2022 to 31st December 2022. Data source will be the electronic record management system of the autonomous community of Valencia (named ABUCASIS), and they will be provided by the Ambulatory Assistance Information System (SIA-GAIA). Investigators will analyze the frequency of ignoring the "Do not do" recommendations previously selected by consensus by sex and age range.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1048000
• Est. completion date: May 10, 2023
• Est. primary completion date: May 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Attending primary care consultation from 1 January 2022 to 31 December 2022.

• Adults

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• Any Condition

Locations

Country	Name	City	State
Spain	Hospital San Juan de Alicante	San Juan De Alicante	Alicante

Sponsors (2)

Lead Sponsor	Collaborator
Universidad Miguel Hernandez de Elche	Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of female patients who were recommended "do not do"	Number of female patients who were recommended "do not do"	From 1st January 2022 to 31 December 2022
Primary	Number of male patients who were recommended "do not do"	Number of male patients who were recommended "do not do"	From 1st January 2022 to 31 December 2022